Physiopathology and genetics of vitiligo

Journal of Autoimmunity

Volumn 25, Issue SUPPL., 2005, Pages 63-68

  Passeron, Thierry ^a   Ortonne, Jean Paul ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Autoimmunity; Genetics; Pathogenesis

Indexed keywords

CALCINEURIN INHIBITOR; HLA ANTIGEN; IMATINIB; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MELANIN; PIMECROLIMUS; STEM CELL FACTOR; STEROID; SUNITINIB; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIBODY DETECTION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL DEATH; CELL DIFFERENTIATION; CELL INFILTRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DEPIGMENTATION; DRUG EFFICACY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEPATITIS B; HEPATITIS C; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; MELANOCYTE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; TH2 CELL; ULTRAVIOLET RADIATION; VITILIGO;

AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY; LINKAGE (GENETICS); MELANOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VITILIGO;

EID: 28444489322     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2005.10.001     Document Type: Review

References (55)

1. C.L. Huang, J.J. Nordlund, and R. Boissy Vitiligo: a manifestation of apoptosis? Am J Clin Dermatol 3 2002 301 308
2. Y. Gauthier, M. Cario-Andre, S. Lepreux, C. Pain, and A. Taieb Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo Br J Dermatol 148 2003 95 101
3. A. Alkhateeb, P.R. Fain, A. Thody, D.C. Bennett, and R.A. Spritz Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families Pigment Cell Res 16 2003 208 214
4. M.D. Njoo, P.I. Spuls, J.D. Bos, W. Westerhof, and P.M. Bossuyt Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature Arch Dermatol 134 1998 1532 1540
5. N.B. Silverberg, P. Lin, L. Travis, J. Farley-Li, A.J. Mancini, and A.M. Wagner Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases J Am Acad Dermatol 51 2004 760 766
6. T. Wilckens, and R. De Rijk Glucocorticoids and immune function: unknown dimensions and new frontiers Immunol Today 18 1997 418 424
7. N.J. Reynolds, and W.I. Al-Daraji Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology Clin Exp Dermatol 27 2002 555 561
8. P.E. Grimes, R. Morris, E. Avaniss-Aghajani, T. Soriano, M. Meraz, and A. Metzger Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines J Am Acad Dermatol 51 2004 52 61
9. J. Shen, S. Bao, and V.E. Reeve Modulation of IL-10, IL-12, and IFN-gamma in the epidermis of hairless mice by UVA (320-400 nm) and UVB (280-320 nm) radiation J Invest Dermatol 113 1999 1059 1064
10. T. Kitajima, and A. Takashima Langerhans cell responses to ultraviolet B radiation J Dermatol Sci 19 1999 153 160
11. V.H. Engelhard, T.N. Bullock, T.A. Colella, S.L. Sheasley, and D.W. Mullins Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy Immunol Rev 188 2002 136 146
12. C. Scheibenbogen, W. Hunstein, and U. Keilholz Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patients Eur J Cancer 30A 1994 1209 1211
13. H. Simsek, C. Savas, H. Akkiz, and H. Telatar Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection Dermatology 193 1996 65 66
14. P. Neumeister, D. Strunk, U. Apfelbeck, H. Sill, and W. Linkesch Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma Lancet 355 2000 1334 1335
15. A. Alajlan, A. Alfadley, and K.T. Pedersen Transfer of vitiligo after allogeneic bone marrow transplantation J Am Acad Dermatol 46 2002 606 610
16. S.B. Cho, M.R. Roh, K.Y. Chung, K.H. Lee, and Y.K. Park Generalized vitiligo after allogeneic bone marrow transplantation Acta Derm Venereol 85 2005 82 83
17. X. Wang, and G.F. Erf Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo J Autoimmun 22 2004 21 30
18. G.F. Erf, T.K. Bersi, X. Wang, G.P. Sreekumar, and J.R. Smyth Jr. Herpesvirus connection in the expression of autoimmune vitiligo in Smyth line chickens Pigment Cell Res 14 2001 40 46
19. I.C. Le Poole, R.M. van den Wijngaard, W. Westerhof, and P.K. Das Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance Am J Pathol 148 1996 1219 1228
20. R. van den Wijngaard, A. Wankowicz-Kalinska, C. Le Poole, B. Tigges, W. Westerhof, and P. Das Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site Lab Invest 80 2000 1299 1309
21. A. Wankowicz-Kalinska, R.M. van den Wijngaard, B.J. Tigges, W. Westerhof, G.S. Ogg, and V. Cerundolo Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo Lab Invest 83 2003 683 695
22. S. Moretti, A. Spallanzani, L. Amato, G. Hautmann, I. Gallerani, and M. Fabiani New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions Pigment Cell Res 15 2002 87 92
23. U.C. Yeo, Y.S. Yang, K.B. Park, H.T. Sung, S.Y. Jung, and E.S. Lee Serum concentration of the soluble interleukin-2 receptor in vitiligo patients J Dermatol Sci 19 1999 182 188
24. F. Mahmoud, H. Abul, D. Haines, C. Al-Saleh, M. Khajeji, and K. Whaley Decreased total numbers of peripheral blood lymphocytes with elevated percentages of CD4+CD45RO+ and CD4+ CD25+ of T-helper cells in non-segmental vitiligo J Dermatol 29 2002 68 73
25. G.S. Ogg, P. Rod Dunbar, P. Romero, J.L. Chen, and V. Cerundolo High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo J Exp Med 188 1998 1203 1208
26. K.S. Lang, C.C. Caroli, A. Muhm, D. Wernet, A. Moris, and B. Schittek HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1 J Invest Dermatol 116 2001 891 897
27. J. Steitz, J. Bruck, J. Lenz, S. Buchs, and T. Tuting Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo J Invest Dermatol 124 2005 144 150
28. T.M. Kroll, H. Bommiasamy, R.E. Boissy, C. Hernandez, B. Nickoloff, and R. Mestril 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo J Invest Dermatol 124 2005 798 806
29. Y. Takechi, I. Hara, C. Naftzger, Y. Xu, and A.N. Houghton A melanosomal membrane protein is a cell surface target for melanoma therapy Clin Cancer Res 2 1996 1837 1842
30. I. Hara, Y. Takechi, and A.N. Houghton Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein J Exp Med 182 1995 1609 1614
31. S.K. Das, P.P. Majumder, R. Chakraborty, T.K. Majumdar, and B. Haldar Studies on vitiligo. I. Epidemiological profile in Calcutta, India Genet Epidemiol 2 1985 71 78
32. P.P. Majumder, J.J. Nordlund, and S.K. Nath Pattern of familial aggregation of vitiligo Arch Dermatol 129 1993 994 998
33. X.J. Zhang, J.B. Liu, J.P. Gui, M. Li, Q.G. Xiong, and H.B. Wu Characteristics of genetic epidemiology and genetic models for vitiligo J Am Acad Dermatol 51 2004 383 390
34. H.C. de Vijlder, W. Westerhof, G.M. Schreuder, P. de Lange, and F.H. Claas Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study Pigment Cell Res 17 2004 270 274
35. A. Alkhateeb, G.L. Stetler, W. Old, J. Talbert, C. Uhlhorn, and M. Taylor Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2 Hum Mol Genet 11 2002 661 667
36. P.R. Fain, K. Gowan, G.S. LaBerge, A. Alkhateeb, G.L. Stetler, and J. Talbert A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci Am J Hum Genet 72 2003 1560 1564
37. R.A. Spritz, K. Gowan, D.C. Bennett, and P.R. Fain Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis Am J Hum Genet 74 2004 188 191
38. M. Arcos-Burgos, E. Parodi, M. Salgar, E. Bedoya, J. Builes, and D. Jaramillo Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA Hum Genet 110 2002 334 342
39. R. Orozco-Topete, J. Cordova-Lopez, J.K. Yamamoto-Furusho, V. Garcia-Benitez, A. Lopez-Martinez, and J. Granados HLA-DRB1*04 is associated with the genetic susceptibility to develop vitiligo in Mexican patients with autoimmune thyroid disease J Am Acad Dermatol 52 2005 182 183
40. H.B. Tastan, A. Akar, F.E. Orkunoglu, E. Arca, and A. Inal Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population Pigment Cell Res 17 2004 181 184
41. M. Zamani, M. Spaepen, S.S. Sghar, C. Huang, W. Westerhof, and L. Nieuweboer-Krobotova Linkage and association of HLA class II genes with vitiligo in a Dutch population Br J Dermatol 145 2001 90 94
42. J. Grabbe, P. Welker, E. Dippel, and B.M. Czarnetzki Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes Arch Dermatol Res 287 1994 78 84
43. S. Nishikawa, M. Kusakabe, K. Yoshinaga, M. Ogawa, S. Hayashi, and T. Kunisada In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development EMBO J 10 1991 2111 2118
44. A. Norris, C. Todd, A. Graham, A.G. Quinn, and A.J. Thody The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo Br J Dermatol 134 1996 299 306
45. R. Kitamura, K. Tsukamoto, K. Harada, A. Shimizu, S. Shimada, and T. Kobayashi Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M J Pathol 202 2004 463 475
46. P. Raanani, J.M. Goldman, and I. Ben-Bassat Challenges in oncology. Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571 J Clin Oncol 20 2002 869 870
47. S. Hasan, K. Dinh, F. Lombardo, F. Dawkins, and J. Kark Hypopigmentation in an African patient treated with imatinib mesylate: a case report J Natl Med Assoc 95 2003 722 724
48. G.G. McGill, M. Horstmann, H.R. Widlund, J. Du, G. Motyckova, and E.K. Nishimura Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability Cell 109 2002 707 718
49. L. Larribere, M. Khaled, S. Tartare-Deckert, R. Busca, F. Luciano, and K. Bille PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes Cell Death Differ 11 2004 1084 1091
50. R. Kos, M.V. Reedy, R.L. Johnson, and C.A. Erickson The winged-helix transcription factor FoxD3 is important for establishing the neural crest lineage and repressing melanogenesis in avian embryos Development 128 2001 1467 1479
51. Y. Guo, R. Costa, H. Ramsey, T. Stames, G. Vance, and K. Robertson The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression Proc Natl Acad Sci USA 99 2002 3663 3667
52. H. Jonsson, and S.L. Peng Forkhead transcription factors in immunology Cell Mol Life Sci 62 2005 397 409
53. A. Alkhateeb, P.R. Fain, and R.A. Spritz Candidate functional promoter variant in the FOXD3 melanoblast developmental regulator gene in autosomal dominant vitiligo J Invest Dermatol 125 2005 388 391
54. S.K. Nath, J.A. Kelly, B. Namjou, T. Lam, G.R. Bruner, and R.H. Scofield Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus Am J Hum Genet 69 2001 1401 1406
55. J.J. Chen, W. Huang, J.P. Gui, S. Yang, F.S. Zhou, and Q.G. Xiong A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families Am J Hum Genet 76 2005 1057 1065